Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 May;55(5):364–369. doi: 10.1136/thorax.55.5.364

Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line

S Varsano 1, M Kaminsky 1, M Kaiser 1, L Rashkovsky 1
PMCID: PMC1745745  PMID: 10770816

Abstract

BACKGROUND—The interrelationship between human airway epithelium and complement proteins may affect airway defence, airway function, and airway epithelial integrity. A study was undertaken to determine (1) whether unstimulated human bronchial epithelium generates complement proteins and expresses cell membrane complement inhibitory proteins (CIP) and (2) whether stimulation by proinflammatory cytokines affects the generation of complement and expression of cell membrane CIP by these cells.
METHODS—Human bronchial epithelium cell line BEAS-2B was cultured in a serum-free medium. Cells were incubated with and without proinflammatory cytokines to assess unstimulated and stimulated generation of complement C3, C1q and C5 (by ELISA), and to examine the expression of cell membrane CIP decay accelerating factor (DAF; CD55), membrane cofactor protein (MCP; CD46), and CD59 (protectin) by flow cytometry analysis.
RESULTS—Unstimulated human bronchial epithelial cell line BEAS-2B in serum-free medium generates complement C3 (mean 32 ng/106 cells/72 h, range 18-52) but not C1q and C5, and expresses cell membrane DAF, MCP, and CD59. Interleukin (IL)-1α (100 U/ml/72 h) and tumour necrosis factor (TNF-α; 1000 U/ml/72 h) increased generation of C3 up to a mean of 78% and 138%, respectively, above C3 generation by unstimulated cells. DAF was the only cell membrane CIP affected by cytokine stimulation. Interferon (IFN)-γ (10 U/ml/72 h) and TNF-α (1000 U/ml/72 h) increased DAF expression up to a mean of 116% and 45%, respectively, above that in unstimulated cells. MCP and CD59 expression was not consistently affected by IL-1α, TNF-α, or IFN-γ.
CONCLUSIONS—Local generation of complement C3 and expression of cell membrane CIP by human bronchial epithelium and its modulation by proinflammatory cytokines might be an additional regulatory mechanism of local airway defence and may affect airway function and epithelial integrity in health and disease.



Full Text

The Full Text of this article is available as a PDF (173.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson M., Michel L., Llull J. B., Pipkorn U. Complement activation on the nasal mucosal surface--a feature of the immediate allergic reaction in the nose. Allergy. 1994 Apr;49(4):242–245. doi: 10.1111/j.1398-9995.1994.tb02656.x. [DOI] [PubMed] [Google Scholar]
  2. Arnaout M. A., Colten H. R. Complement C3 receptors: structure and function. Mol Immunol. 1984 Dec;21(12):1191–1199. doi: 10.1016/0161-5890(84)90009-9. [DOI] [PubMed] [Google Scholar]
  3. Bell D. Y., Haseman J. A., Spock A., McLennan G., Hook G. E. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis. 1981 Jul;124(1):72–79. doi: 10.1164/arrd.1981.124.1.72. [DOI] [PubMed] [Google Scholar]
  4. Bjornson A. B., Mellencamp M. A., Schiff G. M. Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1062–1066. doi: 10.1164/ajrccm/143.5_Pt_1.1062. [DOI] [PubMed] [Google Scholar]
  5. Bloemen P. G., van den Tweel M. C., Henricks P. A., Engels F., Wagenaar S. S., Rutten A. A., Nijkamp F. P. Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1993 Dec;9(6):586–593. doi: 10.1165/ajrcmb/9.6.586. [DOI] [PubMed] [Google Scholar]
  6. Coyne K. E., Hall S. E., Thompson S., Arce M. A., Kinoshita T., Fujita T., Anstee D. J., Rosse W., Lublin D. M. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol. 1992 Nov 1;149(9):2906–2913. [PubMed] [Google Scholar]
  7. Davies A., Simmons D. L., Hale G., Harrison R. A., Tighe H., Lachmann P. J., Waldmann H. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med. 1989 Sep 1;170(3):637–654. doi: 10.1084/jem.170.3.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davis L. S., Patel S. S., Atkinson J. P., Lipsky P. E. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol. 1988 Oct 1;141(7):2246–2252. [PubMed] [Google Scholar]
  9. Fick R. B., Jr, Robbins R. A., Squier S. U., Schoderbek W. E., Russ W. D. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res. 1986 Dec;20(12):1258–1268. doi: 10.1203/00006450-198612000-00014. [DOI] [PubMed] [Google Scholar]
  10. Gaither T. A., Vargas I., Inada S., Frank M. M. The complement fragment C3d facilitates phagocytosis by monocytes. Immunology. 1987 Nov;62(3):405–411. [PMC free article] [PubMed] [Google Scholar]
  11. Gerritsma J. S., Gerritsen A. F., Van Kooten C., Van Es L. A., Daha M. R. Interleukin-1 alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Mol Immunol. 1996 Jul;33(10):847–854. doi: 10.1016/0161-5890(96)84610-4. [DOI] [PubMed] [Google Scholar]
  12. Gosset P., Tsicopoulos A., Wallaert B., Vannimenus C., Joseph M., Tonnel A. B., Capron A. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol. 1991 Oct;88(4):561–571. doi: 10.1016/0091-6749(91)90149-i. [DOI] [PubMed] [Google Scholar]
  13. Hugli T. E. Biochemistry and biology of anaphylatoxins. Complement. 1986;3(3):111–127. doi: 10.1159/000467889. [DOI] [PubMed] [Google Scholar]
  14. Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990 Mar;141(3):765–788. doi: 10.1164/ajrccm/141.3.765. [DOI] [PubMed] [Google Scholar]
  15. Kew R. R., Ghebrehiwet B., Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest. 1985 Mar;75(3):1000–1007. doi: 10.1172/JCI111760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Liszewski M. K., Post T. W., Atkinson J. P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol. 1991;9:431–455. doi: 10.1146/annurev.iy.09.040191.002243. [DOI] [PubMed] [Google Scholar]
  17. Meuth J. L., Morgan E. L., DiSipio R. G., Hugli T. E. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. J Immunol. 1983 Jun;130(6):2605–2611. [PubMed] [Google Scholar]
  18. Moqbel R., Levi-Schaffer F., Kay A. B. Cytokine generation by eosinophils. J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1183–1188. doi: 10.1016/0091-6749(94)90330-1. [DOI] [PubMed] [Google Scholar]
  19. Moutabarrik A., Nakanishi I., Matsumoto M., Zaid D., Seya T. Human glomerular epithelial cells synthesize and secrete the third component of complement. Nephron. 1995;70(1):55–61. doi: 10.1159/000188544. [DOI] [PubMed] [Google Scholar]
  20. Moutabarrik A., Nakanishi I., Namiki M., Hara T., Matsumoto M., Ishibashi M., Okuyama A., Zaid D., Seya T. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells. Lymphokine Cytokine Res. 1993 Jun;12(3):167–172. [PubMed] [Google Scholar]
  21. Rothman B. L., Despins A. W., Kreutzer D. L. Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549. J Immunol. 1990 Jul 15;145(2):592–598. [PubMed] [Google Scholar]
  22. Rothman B. L., Merrow M., Despins A., Kennedy T., Kreutzer D. L. Effect of lipopolysaccharide on C3 and C5 production by human lung cells. J Immunol. 1989 Jul 1;143(1):196–202. [PubMed] [Google Scholar]
  23. Shenoy-Scaria A. M., Kwong J., Fujita T., Olszowy M. W., Shaw A. S., Lublin D. M. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J Immunol. 1992 Dec 1;149(11):3535–3541. [PubMed] [Google Scholar]
  24. Strunk R. C., Eidlen D. M., Mason R. J. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest. 1988 May;81(5):1419–1426. doi: 10.1172/JCI113472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Varsano S., Frolkis I., Ophir D. Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract. Am J Respir Crit Care Med. 1995 Sep;152(3):1087–1093. doi: 10.1164/ajrccm.152.3.7545058. [DOI] [PubMed] [Google Scholar]
  26. Varsano S., Frolkis I., Rashkovsky L., Ophir D., Fishelson Z. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation. Am J Respir Cell Mol Biol. 1996 Dec;15(6):731–737. doi: 10.1165/ajrcmb.15.6.8969267. [DOI] [PubMed] [Google Scholar]
  27. Varsano S., Frolkis I., Shapiro H., Ophir D. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins. Laryngoscope. 1996 May;106(5 Pt 1):599–604. doi: 10.1097/00005537-199605000-00015. [DOI] [PubMed] [Google Scholar]
  28. Varsano S., Rashkovsky L., Shapiro H., Ophir D., Mark-Bentankur T. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance. Clin Exp Immunol. 1998 Aug;113(2):173–182. doi: 10.1046/j.1365-2249.1998.00581.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Varsano S., Rashkovsky L., Shapiro H., Radnay J. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines. Am J Respir Cell Mol Biol. 1998 Sep;19(3):522–529. doi: 10.1165/ajrcmb.19.3.3181. [DOI] [PubMed] [Google Scholar]
  30. van de Graaf E. A., Jansen H. M., Bakker M. M., Alberts C., Eeftinck Schattenkerk J. K., Out T. A. ELISA of complement C3a in bronchoalveolar lavage fluid. J Immunol Methods. 1992 Mar 4;147(2):241–250. doi: 10.1016/s0022-1759(12)80014-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES